Search results
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 4 days ago"LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial" was originally...
Stage 4 Lung Cancer
Health via Yahoo News· 7 days agoTempura / Getty Images Medically reviewed by Gagandeep Brar, MDMedically reviewed by Gagandeep Brar, MD Lung cancer is a type of cancer that grows in...
Mouse study suggests cancer drug could be used to target protein connection that spurs Parkinson's...
Medical Xpress· 22 hours agoNotably, the researchers say, Lag3 is already the target of a combination cancer drug approved by the U.S. Food and Drug Administration ...
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug...
San Mateo Daily Journal· 6 days agoInvestor webcast on or before July 23 will include updates on Jaguar's cancer supportive care...
UroGen Catapults On 'Unprecedented' Results For Gel-Based Cancer Drug
Investor's Business Daily· 5 days agoUroGen stock rocketed Thursday on "unprecedented" test results for its bladder cancer treatment, a...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
Mitophagy and cancer: Researchers describe a new model system to enrich sub-populations of cancer...
Medical Xpress· 20 hours agoA new research paper was published on the cover of Aging, titled, "Mitophagy and cancer: role of BNIP3/BNIP3L as energetic drivers of stemness features, ATP production, proliferation, and cell migration."
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca's Imfinzi (durvalumab), in combination with chemotherapy, has received approval from the...
Cancer’s Molecular Achilles Heel: Key to Improving Cancer Treatments Discovered
SciTechDaily· 3 days agoResearch at the University of Würzburg aims to refine these inhibitors to target more specifically...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 6 days agoLantern Pharma Inc. (NASDAQ:LTRN), a company leveraging artificial intelligence (AI) in cancer...